0001144204-06-045069.txt : 20061103 0001144204-06-045069.hdr.sgml : 20061103 20061102180320 ACCESSION NUMBER: 0001144204-06-045069 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20061102 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20061103 DATE AS OF CHANGE: 20061102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RELIV INTERNATIONAL INC CENTRAL INDEX KEY: 0000768710 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 371172197 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19932 FILM NUMBER: 061184116 BUSINESS ADDRESS: STREET 1: 136 CHESTERFIELD INDUSTRIAL BLVD STREET 2: P O BOX 405 CITY: CHESTERFIELD STATE: MO ZIP: 63006-0405 BUSINESS PHONE: 636-537-9715 MAIL ADDRESS: STREET 1: 136 CHESTERFIELD INDUSTRIAL BLVD STREET 2: P O BOX 405 CITY: CHESTERFIELD STATE: MO ZIP: 63006-0405 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN LIFE INVESTORS INC DATE OF NAME CHANGE: 19920315 8-K 1 v056372_8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 2, 2006

RELIV’ INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction of incorporation)

1-11768	37-1172197
(Commission File Number)	(IRS Employer Identification No.)

136 Chesterfield Industrial Boulevard Chesterfield, Missouri 63005
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (636) 537-9715

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))

Item 8.01 Other Events.

On November 2, 2006, Relìv International, Inc. issued a press release announcing the planned introduction of a new weight-management product in early 2007. A copy of the press release is attached as Exhibit 99 hereto.

Item 9.01 Financial Statements and Exhibits.

(c)

Exhibits

Press Release dated November 2, 2006 captioned: “Relìv International to Introduce New Weight-Management Product.”

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, Relìv International, Inc. has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized, in the City of Chesterfield, State of Missouri, on November 2, 2006.


	RELIV’ INTERNATIONAL, INC.

	By:	/s/ Steven D. Albright
		Steven D. Albright
		Chief Financial Officer

EXHIBIT INDEX

Exhibit No.

Description

99	Press Release dated November 2, 2006 captioned: “Relìv International to Introduce New Weight-Management Product.”

EX-99 2 v056372_ex99.htm

Exhibit 99

NEWS RELEASE

FOR FURTHER INFORMATION, CONTACT:

R. Scott Montgomery	Barry A. Murov
Senior Vice President	Director of Corporate Communications
(636) 733-1305	(636) 733-1303

RELIV INTERNATIONAL TO INTRODUCE

NEW WEIGHT-MANAGEMENT PRODUCT

FOR IMMEDIATE RELEASE

CHESTERFIELD, Mo., Nov. 2, 2006 - Reliv International, Inc., (NASDAQ:RELV), a manufacturer and marketer of proprietary nutritional supplements, today announced it will introduce a new weight-management product in early 2007. The new product is the culmination of more than a year of research and development by Reliv Vice President Dr. Carl W. Hastings.

“We have developed a proprietary product using the latest technology to create a unique blend of ingredients that is designed to curb appetite, enhance lean body mass and inhibit fat production,” Hastings said. “This product is for consumers interested in accelerating their weight loss. The ingredients, as in all Reliv nutritional supplements, are shown by scientific research to be effective and safe,” he added.

“Obesity is one of the most common health problems in the United States. Medical research shows that it may increase your risk of diabetes, high blood pressure, heart disease and other ailments. This product is designed to be part of a program including proper diet and exercise that will help people lose weight and avoid the health concerns related to obesity,” said Hastings.

About Reliv

Reliv International, Inc., based in suburban St. Louis, Mo., develops, manufactures and markets a proprietary line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management and sports nutrition. Reliv sells its products through an international network marketing system of approximately 65,000 independent distributors. Reliv International's common stock trades on NASDAQ under the symbol RELV. Additional information about Reliv can be obtained on the Web at www.reliv.com.

# # #

Statements made in this release that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or similar expressions.